Bioasis Technologies, Inc . (OTCQB:BIOAF) (CVE:BTI) CEO Deborah Rathjen sat down with Proactive's Christine Corrado at the Biotech Showcase 2020 in San Francisco. The Guilford, Connecticut-based company is developing a proprietary technology to delivery therapeutics across the blood brain barrier and treating CNS disorders in brain cancers and neurodegenerative diseases.
Bioasis Technologies secures patents in key global markets
Quick facts: Bioasis Technologies Inc.
Price: 0.1591 USD
Market Cap: $10.05 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE